Tirzepatide price in South Africa: what drives the cost

How much does tirzepatide cost per month in South Africa?

About R3,600 a month at the entry strength, on the most recent published figure. Reuters reported that number for Mounjaro, the brand that carries tirzepatide in South Africa, in March 2026. Each KwikPen holds four weekly doses, so a pen price sits close to a monthly medicine cost, and every step up the dose ladder costs more.

The exact rand figure for any strength is public. Each pen strength carries its own regulated national price, published on the Department of Health's Medicine Price Registry, and the Single Exit Price section below explains how to read it. We do not sell medicine. Prices vary by pharmacy and dose; confirm with your pharmacy.

The pen is also not the whole bill. Doctor consultations, follow-up reviews and any baseline blood tests sit alongside it, and the budget section at the end of this guide breaks those down.

What drives the tirzepatide price in South Africa?

Four things set the number: the regulated national price of each pen strength, the dose you are on, the pharmacy's regulated dispensing fee, and the absence of any generic competitor. Dose is the biggest variable in practice, because each step up the schedule moves you into a higher-priced pen.

Tirzepatide reaches South African pharmacies under one brand, Mounjaro, distributed by Aspen Pharmacare in partnership with Eli Lilly. With a single patented product on the market, the molecule's price and the brand's price are the same thing, and no cheaper registered alternative exists at any strength.

The brand-level detail, including the vial launch history and medical aid motivation letters, sits in how much Mounjaro costs in South Africa. This guide stays with the molecule: the pricing system, the pen formats and the economics underneath the figures.

How is the tirzepatide price regulated?

Through the Single Exit Price system. Every medicine in South Africa's private sector carries one national price, set by the manufacturer within the Medicines Act rules and registered with the Department of Health. Every pharmacy sells a given pen at that figure, and discounting it is unlawful.

Pharmacies earn from a regulated dispensing fee added on top, tiered to the medicine's price. That fee is the reason two chains can show slightly different till prices for the identical pen.

Prices also move on a fixed annual cycle rather than at will. The national Pricing Committee capped the 2026 increase at 1.47%, down from 5.25% in 2025, and manufacturers may hold or cut prices below the cap but never exceed it.

You can check any figure yourself on the Medicine Price Registry at mpr.gov.za, the Department of Health's public database of every registered medicine's Single Exit Price and maximum dispensing fee. A quoted price far from the registry figure, in either direction, is a reason for suspicion rather than excitement.

What does a tirzepatide 30 mg or 60 mg pen mean?

Those numbers describe total pen content, not the weekly dose. A Mounjaro KwikPen delivers four weekly doses, so a pen holding 30 mg of tirzepatide is the 7.5 mg weekly strength, and a 60 mg pen is the 15 mg maximum strength. Searches for a 30 mg or 60 mg price are asking about those two pens.

The distinction matters when you compare quotes. A figure quoted per pen covers a month; a figure quoted per vial or per single dose does not, and multiplying it by four changes the comparison completely. The pen format itself is unpacked in the Mounjaro KwikPen in South Africa.

Bulk "30 mg" and "60 mg" tirzepatide vials offered on websites and social media are a different matter. Registered tirzepatide reaches South African pharmacies as Eli Lilly's single-dose vials and the KwikPen, so multi-dose vials sold online under those labels fall outside the registered supply chain, and the compounded-product section below explains what regulators did about them.

Why does the cost rise with your dose?

The cost rises because each pen strength is its own product with its own regulated price, and higher strengths contain more active ingredient. Treatment starts at 2.5 mg weekly and steps up gradually, typically every four weeks where needed and tolerated, so the monthly cost climbs across the first six months.

Budget for the strength you expect to hold, not the starting pen. Many people settle at a middle dose where results and side effects balance, and there is no clinical prize for reaching 15 mg. In the SURMOUNT-1 trial, average weight loss over 72 weeks was 15% of body weight on 5 mg, 19.5% on 10 mg and 20.9% on 15 mg. Individual results vary.

Side effects belong in the same conversation. Nausea, diarrhoea, constipation and vomiting cluster around dose increases, which is a clinical reason to climb slowly rather than race to a higher-priced pen. Tirzepatide is also not suitable in pregnancy or with a personal or family history of medullary thyroid cancer or MEN2 syndrome, and a doctor screens for both before confirming any treatment plan.

What is the tirzepatide price at Dischem or Clicks?

Dischem, Clicks and independent pharmacies all charge essentially the same for tirzepatide, because the Single Exit Price system sets one national price for each pen strength. The visible difference at the till is the regulated dispensing fee, which is small next to the pen itself.

Do not expect the number on a chain's website. Scheduled medicines are not advertised to the public in South Africa, so product pages usually carry no price at all. Phoning the branch dispensary gets you the current figure for your strength and, just as usefully, whether it is in stock.

Courier pharmacies are the option many people miss. Licensed couriers dispense at the same regulated price and deliver in cold-chain packaging, which solves branch-level stock hunting. We do not sell medicine. Prices vary by pharmacy and dose; confirm with your pharmacy.

Is the tirzepatide price in South Africa coming down?

No cut has been announced, but downward pressure on the class is real and visible in published figures. Competition between the two originator manufacturers has already moved semaglutide prices sharply, and the regulated annual adjustment cycle is where any tirzepatide change would first appear.

Reuters reported in March 2026 that Novo Nordisk had cut Wegovy's South African price for a second time since its August 2025 launch, with the lowest dose falling from R3,090 to R1,873 and the highest dropping 27% to R3,746. The same report put Mounjaro's share of the local market at 52% at the end of January, the competitive backdrop to those cuts. We do not sell medicine. Prices vary by pharmacy and dose; confirm with your pharmacy.

A generic route stays closed for now. Tirzepatide's patents run for years yet, and no generic version is registered with SAHPRA. Semaglutide got there first, with the first generic approved for type 2 diabetes in 2026; generic Ozempic in South Africa covers what that arrival means for prices, and tirzepatide is years away from the same point.

Why was compounded tirzepatide cheaper, and where did it go?

Compounded tirzepatide undercut the registered pen because it skipped the entire registration system, and SAHPRA has now recalled it. In June 2026 the regulator ordered a Class I recall, its most serious category, of iDEXIS-branded compounded semaglutide and tirzepatide products sold for weight loss.

In July 2026, SAHPRA, the South African Pharmacy Council and the HPCSA jointly warned that continued dispensing or use of the recalled products is unlawful, and flagged disciplinary action for health professionals who carry on. The investigation cited illegally imported active ingredients and inadequate sterile manufacturing conditions.

That is the answer to any bargain tirzepatide still advertised online: a recalled product has no lawful price, and a seller offering one is operating outside the regulated supply chain. Suspicious products can be reported to SAHPRA's 24-hour hotline on 0800 204 307.

Why is there no Zepbound price in South Africa?

There is no Zepbound price in South Africa because Zepbound is not registered here. It is the American brand name for tirzepatide used in weight management, SAHPRA has not registered it, and it cannot lawfully be sold locally. In South Africa, one brand carries the molecule for both registered uses: Mounjaro.

Mounjaro's registration covers type 2 diabetes, from its December 2024 launch, and chronic weight management, added by SAHPRA in October 2025. An American Zepbound figure, whether a list price or a coupon price, therefore tells you nothing about a South African till price, which the Single Exit Price system sets independently. The full local picture is in Zepbound in South Africa.

Is tirzepatide more expensive than semaglutide in South Africa?

Yes on current published figures. Reuters reported Mounjaro's entry strength at about R3,600 a month in March 2026, close to the R3,746 published for Wegovy's highest dose after its price cuts, and Wegovy's lowest dose now costs R1,873, roughly half of Mounjaro's starting point. We do not sell medicine. Prices vary by pharmacy and dose; confirm with your pharmacy.

The molecules dose differently, so a per-milligram comparison misleads, and price is one axis of several. The trial evidence behind the two medicines is compared in semaglutide vs tirzepatide; side-effect experience, your medical history and availability all sit alongside cost, and the right option is decided by a doctor on assessment.

Does medical aid cover the tirzepatide price?

Usually not for weight management. Obesity is not a Prescribed Minimum Benefit condition, so most schemes exclude weight-loss medicine from standard cover and most people pay out of pocket. Some schemes do fund tirzepatide for type 2 diabetes under chronic benefits.

Two checks are worth making before assuming a cash price. Ask your scheme whether your plan can pay from a medical savings account at the till, and ask for its exclusion list and chronic criteria in writing. Scheme rules also shift year to year as these medicines become mainstream, so an old exclusion list is not a safe guide to the current one.

How applications, motivations and exclusions work in practice is unpacked in does medical aid pay for Mounjaro, and our medical aid page explains how cover questions fit into a doctor-led treatment plan.

What should a full tirzepatide budget include?

A full tirzepatide budget includes the medicine, the doctor time around it and the consumables. That means an initial assessment, follow-up reviews as the dose changes, any baseline blood tests the doctor requests, pen needles and a sharps container. Consultation fees vary by practice, so ask for fees upfront when comparing.

Think in years rather than months. Obesity is managed as a long-term condition, and the dose typically climbs across the first six months, so the medicine line grows before it stabilises. A budget that only works at the starting strength for three months sets up an exit at exactly the wrong moment.

How the medicine, consultations and monitoring add up across the whole class, and where costs can be trimmed safely, is covered in GLP-1 treatment costs in South Africa.

Frequently asked questions